Presenter: Dr. Michael Allan James McCormack BSc (Pharm) Pharm D
0:00
In episode 480, James and Mike talk about two recent meta-analyses that have done a solid job of looking at the impact of lowering blood pressure and using SGLT-2s and GLP-1s to reduce risk. Both publications lend credence to the concept of focusing much more on risk reduction goals than blood pressure or glucose thresholds….

November 12, 2021
Presenter(s):
Dr. Michael Allan James McCormack BSc (Pharm) Pharm D